![Michael Shleifer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Shleifer
Algemeen Directeur bij
BIOTECH ACQUISITION COMPANY
Profiel
Michael Shleifer is the founder of Vanteres Pte Ltd. (founded in 2016), SPRIM (founded in 2001), Sprim Ventures Pte Ltd. (founded in 2015), and Sprim Global Investments Pte Ltd. (founded in 2001).
He holds the title of Managing Partner at SPRIM, Sprim Ventures Pte Ltd., and Sprim Global Investments Pte Ltd. Dr. Shleifer is also the founder of Travecta Therapeutics Pte Ltd. Dr. Shleifer's current job(s) include Chairman & Chief Executive Officer at Biotech Acquisition Co., Director at Fibronostics Pte Ltd., Director at Vanteres Pte Ltd., Director at Phoska Biopharma Pte Ltd., Director at Nereus Therapeutics Pte Ltd., Director at Neurtheia Therapeutics Pte Ltd., and Director at Integrale Pte Ltd. In terms of education, Dr. Shleifer graduated from Sciences Po and holds multiple doctorate degrees from Université de Paris 5 René Descartes.
Actieve functies van Michael Shleifer
| Bedrijven | Functie | Begin |
|---|---|---|
| BIOTECH ACQUISITION COMPANY | Algemeen Directeur | 01-09-2020 |
Sprim Ventures Pte Ltd.
 Sprim Ventures Pte Ltd. Investment ManagersFinance Sprim Ventures invests in companies located in Singapore. invests in companies primarily located in North America. The firm targets companies operating in the fields of artificial intelligence in healthcare, digital health and biotech sectors. It provides financing for early stage companies. | Oprichter | 01-01-2015 |
Sprim Global Investments Pte Ltd.
 Sprim Global Investments Pte Ltd. Investment ManagersFinance SPRIM Global Investments invests in companies located in the United States, Asia, Pacific and Europe. The firm focuses on digital clinical solutions, pharma R&D services, biotech and medtech sectors. It participates in the form of equity and debt in early stage capital requirements. | Oprichter | 01-01-2001 |
Fibronostics Pte Ltd.
 Fibronostics Pte Ltd. Information Technology ServicesTechnology Services Specializes in algorithm-based non-invasive diagnostic solutions | Directeur/Bestuurslid | - |
Neurtheia Therapeutics Pte Ltd. | Directeur/Bestuurslid | - |
Phoska Biopharma Pte Ltd.
 Phoska Biopharma Pte Ltd. BiotechnologyHealth Technology Engages in research and experimental development on biotechnology, life & medical sciences | Directeur/Bestuurslid | - |
Vanteres Pte Ltd.
 Vanteres Pte Ltd. BiotechnologyHealth Technology Develops diagnostics and treatment solutions | Directeur/Bestuurslid | - |
Integrale Pte Ltd. | Directeur/Bestuurslid | - |
SPRIM
 SPRIM Medical/Nursing ServicesHealth Services Provides health prevention research and information consulting services | Oprichter | 01-01-2001 |
Eerdere bekende functies van Michael Shleifer
| Bedrijven | Functie | Einde |
|---|---|---|
| ░░░░░░░░ ░░░ ░░░░ | ░░░░░░░░░ | - |
| ░░░░░░ ░░░░░░░░░░░░ ░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░░ ░░░░░░░░░░░░ ░░░ ░░░░ | ░░░░░░░░░ | - |
Opleiding van Michael Shleifer
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
1
Eerstegraads connecties
13
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 13 |
|---|---|
Sciences Po
 Sciences Po Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SPRIM
SPRIM Medical/Nursing ServicesHealth Services Provides health prevention research and information consulting services | Health Services |
Université de Paris 5 René Descartes
 Université de Paris 5 René Descartes Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sprim Ventures Pte Ltd.
Sprim Ventures Pte Ltd. Investment ManagersFinance Sprim Ventures invests in companies located in Singapore. invests in companies primarily located in North America. The firm targets companies operating in the fields of artificial intelligence in healthcare, digital health and biotech sectors. It provides financing for early stage companies. | Finance |
Travecta Therapeutics Pte Ltd.
 Travecta Therapeutics Pte Ltd. Packaged SoftwareTechnology Services Develops a novel chemistry platform for delivery of therapies to the brain | Technology Services |
Fibronostics Pte Ltd.
Fibronostics Pte Ltd. Information Technology ServicesTechnology Services Specializes in algorithm-based non-invasive diagnostic solutions | Technology Services |
Vanteres Pte Ltd.
Vanteres Pte Ltd. BiotechnologyHealth Technology Develops diagnostics and treatment solutions | Health Technology |
Phoska Biopharma Pte Ltd.
Phoska Biopharma Pte Ltd. BiotechnologyHealth Technology Engages in research and experimental development on biotechnology, life & medical sciences | Health Technology |
Nereus Therapeutics Pte Ltd.
 Nereus Therapeutics Pte Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in research and experimental development on biotechnology, life and medical science | Commercial Services |
Biotech Acquisition Co.
 Biotech Acquisition Co. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Sprim Global Investments Pte Ltd.
Sprim Global Investments Pte Ltd. Investment ManagersFinance SPRIM Global Investments invests in companies located in the United States, Asia, Pacific and Europe. The firm focuses on digital clinical solutions, pharma R&D services, biotech and medtech sectors. It participates in the form of equity and debt in early stage capital requirements. | Finance |
Neurtheia Therapeutics Pte Ltd. | |
Integrale Pte Ltd. |
